OASC - ETF AI Analysis
Top Page
OneAscent Small Cap Core ETF (OASC)
OASC (OneAscent Small Cap Core ETF) has a solid overall rating, largely supported by strong holdings like Royalty Pharma, Northern Trust, Ralph Lauren, and Hanover Insurance, which all show robust financial performance, positive earnings calls, and generally supportive technical or valuation backdrops. These strengths are partly offset by weaker names such as Hasbro, where high debt and negative profitability margins are concerns, and by some holdings facing revenue growth or cash flow challenges, making the main risk the fund’s exposure to smaller companies that can be more sensitive to financial and growth headwinds.
OASC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 97.22M
- Region
- North America
- Expense Ratio
- 0.69%
- Beta
- 0.94
- Issuer
- Oneascent
- Inception Date
- Jun 13, 2024
- Dividend Yield
- 0.48%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
OASC Summary
The OneAscent Small Cap Core ETF (OASC) focuses on smaller U.S. companies that have room to grow, rather than tracking a specific index. It invests across many sectors, including financials, technology, and health care, and holds well-known names like Hasbro and Ralph Lauren alongside lesser-known small businesses. Someone might consider this ETF to seek long-term growth and add diversification beyond large, familiar stocks. However, small-cap stocks can be more volatile than larger companies, so the value of this ETF can go up and down more sharply with changes in the market.
How much will it cost me?
The ETF has an expense ratio of 0.69%, which means you’ll pay about $6.90 per year for every $1,000 you invest. This cost is higher than the average ETF because it’s actively managed rather than simply tracking a broad market index.
What would affect this ETF?
This U.S.-focused small-cap ETF could benefit if the American economy grows steadily, interest rates eventually ease, and sectors like financials, technology, and consumer-related companies see stronger demand, helping holdings such as Reinsurance Group, Hasbro, and Ralph Lauren. On the downside, higher interest rates, an economic slowdown that hits small businesses harder, or sector-specific challenges in finance and tech could increase volatility and weigh on future returns.
OASC Top 10 Holdings
This small-cap fund leans heavily into U.S. financials and niche industrial names, with a few standout winners doing the heavy lifting. HF Sinclair has been a powerful engine, rising strongly and giving the portfolio an energy boost, while Royalty Pharma’s steady climb in biotech royalties adds a defensive growth tilt. Hasbro has bounced back, helping consumer exposure, though its debt load keeps it a bit shaky. Reinsurance Group and Northern Trust are more steady than spectacular, and names like Watts Water are treading water, slightly holding back momentum. Overall, it’s a U.S.-centric, small-cap mix with financials and specialty cyclicals in the driver’s seat.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 RGA | Reinsurance Group | 4.05% | $3.94M | $17.10B | 36.99% | 74Outperform |
 HAS | Hasbro | 2.84% | $2.76M | $16.63B | 55.21% | 56Neutral |
 RPRX | Royalty Pharma | 2.62% | $2.55M | $38.61B | 65.03% | 79Outperform |
 NJR | New Jersey Resources | 2.59% | $2.52M | $5.51B | 20.25% | 64Neutral |
 NTRS | Northern | 2.20% | $2.14M | $31.29B | 34.65% | 78Outperform |
 RL | Ralph Lauren | 2.10% | $2.04M | $22.42B | 19.53% | 78Outperform |
 AMG | Affiliated Managers | 1.76% | $1.71M | $9.39B | 40.25% | 74Outperform |
 CCK | Crown Holdings | 1.72% | $1.68M | $13.11B | 26.30% | 73Outperform |
 WTS | Watts Water Technologies | 1.58% | $1.53M | $11.55B | 31.34% | 77Outperform |
 THG | Hanover Insurance | 1.54% | $1.50M | $8.35B | 37.40% | 77Outperform |
OASC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OASC, the sentiment is Negative. The current price of 32.71 is below the 20-day moving average (MA) of 34.11, below the 50-day MA of 34.18, and below the 200-day MA of 33.13, indicating a bearish trend. The MACD of -0.21 indicates Positive momentum. The RSI at 34.37 is Neutral, neither overbought nor oversold. The STOCH value of 19.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OASC.
OASC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| OASC | $32.71 | $36.00(10.06% Upside) | $97.22M | 0.69% | 68Neutral |
 POMG | $26.58 | $33.53(26.13% Upside) | $69.70M | 0.68% | 66Neutral |
 MYLD | $32.86 | $37.58(14.35% Upside) | $53.83M | 0.62% | 68Neutral |
 BCSM | $24.30 | $30.93(27.32% Upside) | $35.82M | 0.75% | 58Neutral |
 IVSS | $29.83 | $36.74(23.17% Upside) | $29.97M | 0.59% | 69Neutral |
 BRSM | $24.91 | $30.21(21.29% Upside) | $26.79M | 0.38% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| OASC | OneAscent Small Cap Core ETF | 32.71 | 3.99 | 13.88% | |
| POMG | PRIMECAP Odyssey Discovery ETF | 26.58 | 1.06 | 4.15% | |
| MYLD | Cambria Micro and SmallCap Shareholder Yield ETF | 32.86 | 7.83 | 31.30% | |
| BCSM | Baron SMID Cap ETF | 24.30 | -0.01 | -0.03% | |
| IVSS | Applied Finance IVS US SMID ETF | 29.83 | 4.61 | 18.28% | |
| BRSM | MFS Blended Research Small-Mid Cap ETF | 24.91 | -0.13 | -0.51% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.